Redwood Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,484
Closed -$415K 122
2024
Q3
$415K Sell
3,484
-466
-12% -$62.1K 0.12% 103
2024
Q2
$564K Hold
3,950
0.19% 98
2024
Q1
$507K Buy
3,950
+40
+1% +$4.76K 0.15% 104
2023
Q4
$404K Sell
3,910
-284
-7% -$28.1K 0.11% 107
2023
Q3
$381K Buy
4,194
+30
+0.7% +$2.64K 0.05% 104
2023
Q2
$337K Buy
+4,164
New +$340K 0.04% 107

Other funds holding NVO

Redwood Investments's NVO Position: Q4 2024 in Review

Redwood Investments sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 3,484 shares — an estimated $415K sold.

Redwood Investments first reported a position in NVO in Q2 2023 and held it in 6 quarters. The position peaked at $564K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Redwood Investments reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Redwood Investments sold 3,484 Novo Nordisk shares in Q4 2024, an estimated $415K.
  • Redwood Investments first reported a position in Novo Nordisk in Q2 2023 and held it in 6 quarters.
  • Redwood Investments's Novo Nordisk position peaked at $564K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Redwood Investments's 13F filing for Q4 2024, filed 14 Feb 2025.